Dr Peter Yellowlees comments on research that finally settles the question of whether statin use lowers the incidence of dementia.

A new meta-analysis explores whether or not ketamine for treating depression might be ready for the clinic.

Dr Peter Yellowlees talks about a randomized controlled trial studying the effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant medication.

Dr Peter Yellowlees discusses integrated medical/behavioral care vs usual primary care for child and adolescent behavioral health.

Dr Yellowlees discusses findings of a Cochrane Review that checks the value of the Mini-Mental State Examination for predicting which patients will advance to dementia.

Evidence suggests that psychological treatments for depression in primary care can include less resource-intensive types of therapy.

In his first Medscape video commentary, Dr Stephen Strakowski discusses the programmatic management of bipolar disorder.

Dr Jeffrey Lieberman's not-so-pleased reaction to a recent New York Times article on mental illness.

Dr Lieberman discusses the experience with ketamine and its promise for patients with refractory psychiatric conditions but cautions that it be used carefully and in a professional and rigorous way.

Work is good for mental health, but it can be difficult for severely mentally ill individuals to find and hold jobs. Can we do a better job of helping them?